Cargando…
Comparison of the efficacy and safety of oligomeric proanthocyanidins and nifedipine in patients with primary Raynaud’s phenomenon: An open-label, randomized, prospective pilot study
Autores principales: | Lee, Kyung-ann, Jung, Seung-hwan, Kim, Jong-sun, Kim, Hyun-sook |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Turkish League Against Rheumatism
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10689017/ https://www.ncbi.nlm.nih.gov/pubmed/38046252 http://dx.doi.org/10.46497/ArchRheumatol.2023.9212 |
Ejemplares similares
-
Development of a UV-Stabilized Topical Formulation of Nifedipine for the Treatment of Raynaud Phenomenon and Chilblains
por: Wasan, Ellen K., et al.
Publicado: (2019) -
Raynaud’s phenomenon
por: Solomons, HD
Publicado: (2011) -
Raynaud's Phenomenon
por: Shah, Jehan, et al.
Publicado: (2013) -
Audiovestibular Manifestations in Patients with Primary Raynaud’s Phenomenon and Raynaud’s Phenomenon Secondary to Systemic Sclerosis
por: Amor-Dorado, Juan Carlos, et al.
Publicado: (2023) -
Advances in the treatment of Raynaud’s phenomenon
por: Levien, Terri L
Publicado: (2010)